+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gatifloxacin Market by Product Type (Injectable, Ophthalmic Drops, Oral Tablets), Application (Dermal Infections, Ocular Infections, Respiratory Tract Infections), Route Of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Gatifloxacin Market by Product Type (Injectable, Ophthalmic Drops, Oral Tablets), Application (Dermal Infections, Ocular Infections, Respiratory Tract Infections), Route Of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Gatifloxacin Market by Product Type (Injectable, Ophthalmic Drops, Oral Tablets), Application (Dermal Infections, Ocular Infections, Respiratory Tract Infections), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967939
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Gatifloxacin market is experiencing dynamic evolution, propelled by technological innovation, regulatory shifts, and strategic realignments across global healthcare landscapes. Senior decision-makers will benefit from a comprehensive perspective on the forces shaping competitive positioning, operational resilience, and growth opportunities within this essential antibiotic segment.

Market Snapshot: Strategic Overview of the Gatifloxacin Market

The Gatifloxacin market expanded from USD 331.32 million in 2024 to USD 348.23 million in 2025, with continued growth forecast at a CAGR of 4.86% to reach USD 440.68 million by 2030. This trajectory is driven by widespread adoption in hospital and outpatient settings, alongside an increased focus on treatment-resistant bacterial infections. Supply chain realignments, evolving healthcare policies, and shifting regulatory frameworks are influencing both pricing and availability across key regions.

Scope & Segmentation: Defining Drivers, Applications, and Regional Dynamics

This report provides detailed insight across all critical dimensions of the Gatifloxacin market. The analysis encompasses:

  • Product Types: Injectable (200 mg, 400 mg), Ophthalmic Drops (0.3%), Oral Tablets (200 mg, 400 mg)
  • Therapeutic Applications: Dermal infections, Ocular infections, Respiratory tract infections, Urinary tract infections
  • Routes of Administration: Ophthalmic, Oral, Parenteral
  • Distribution Channels: Hospital pharmacy (private and public), Online pharmacy, Retail pharmacy (chain and independent)
  • Key Regions: Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Cadila Healthcare Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sandoz International GmbH
  • Emerging Formulation Technologies: Sustained-release ophthalmic matrices, intravenous nanocarriers, digital clinical trial monitoring, adaptive manufacturing processes

Key Takeaways for Decision-Makers

  • Gatifloxacin continues to demonstrate clinical versatility, with injectable and oral formulations supporting both acute and chronic care needs in hospital and outpatient environments.
  • Advancements in ophthalmic delivery systems and nanotech-based intravenous delivery are enabling targeted treatments while minimizing systemic side effects.
  • Regionally, uptake is shaped by reimbursement policies, access initiatives, and variable infrastructure maturity, highlighting the importance of tailored market strategies in established and emerging economies.
  • Strategic partnerships and technology integration among leading players are creating differentiated offerings and supporting competitive resilience.
  • The growing adoption of digital health platforms, including telepharmacy and remote patient monitoring, is expanding market reach and supporting adherence efforts.

Assessing Tariff Impact and Supply Chain Adaptation

United States tariff implementation in 2025 has prompted market participants to reassess sourcing, diversify procurement, and optimize production locations. These changes are motivating contract manufacturers and distributors to adopt advanced inventory strategies and invest in process innovations, ensuring continuity and cost controls despite external pressures. Healthcare providers are adopting flexible formularies to maintain patient access to essential treatments while managing budget considerations.

Methodology & Data Sources

This report integrates primary engagement with key opinion leaders, R&D executives, and regulatory experts. It draws on secondary research from peer-reviewed journals, patent filings, clinical trial databases, and guidance documents, triangulated for reliability. Quantitative benchmarks and qualitative insights are further validated through scenario modeling and sensitivity checks.

Why This Report Matters

  • Enables informed decisions on portfolio prioritization, investment allocation, and strategic partnerships in a fast-evolving antibiotic market.
  • Delivers actionable intelligence on regulatory shifts, supply chain trends, and regional nuances for streamlined go-to-market execution.
  • Empowers organizational agility with robust scenario analyses and data-driven projections tailored to senior stakeholders' needs.

Conclusion

This research equips industry leaders with a robust foundation to navigate the Gatifloxacin market’s complexity and seize emerging growth opportunities. Leverage these insights to drive operational resilience, optimize resource deployment, and support evidence-based decision-making in a global pharmaceutical landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding use of generic gatifloxacin formulations in emerging markets due to pricing pressure
5.2. Rising antibiotic resistance prompting renewed clinical trials for gatifloxacin efficacy in complex infections
5.3. Increased regulatory scrutiny after safety concerns driving reformulation strategies for gatifloxacin products
5.4. Strategic partnerships between pharmaceutical companies and research institutes to accelerate gatifloxacin pipeline development
5.5. Emergence of novel delivery systems enhancing gatifloxacin bioavailability in targeted patient populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gatifloxacin Market, by Product Type
8.1. Introduction
8.2. Injectable
8.2.1. 200 Mg
8.2.2. 400 Mg
8.3. Ophthalmic Drops
8.3.1. 0.3%
8.4. Oral Tablets
8.4.1. 200 Mg
8.4.2. 400 Mg
9. Gatifloxacin Market, by Application
9.1. Introduction
9.2. Dermal Infections
9.3. Ocular Infections
9.4. Respiratory Tract Infections
9.5. Urinary Tract Infections
10. Gatifloxacin Market, by Route Of Administration
10.1. Introduction
10.2. Ophthalmic
10.3. Oral
10.4. Parenteral
11. Gatifloxacin Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Private Hospital Pharmacy
11.2.2. Public Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.4.1. Chain Retail Pharmacy
11.4.2. Independent Retail Pharmacy
12. Americas Gatifloxacin Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gatifloxacin Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gatifloxacin Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sun Pharmaceutical Industries Limited
15.3.2. Dr. Reddy's Laboratories Limited
15.3.3. Cipla Limited
15.3.4. Lupin Limited
15.3.5. Aurobindo Pharma Limited
15.3.6. Torrent Pharmaceuticals Limited
15.3.7. Cadila Healthcare Limited
15.3.8. Viatris Inc.
15.3.9. Teva Pharmaceutical Industries Ltd
15.3.10. Sandoz International GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GATIFLOXACIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GATIFLOXACIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GATIFLOXACIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GATIFLOXACIN MARKET: RESEARCHAI
FIGURE 24. GATIFLOXACIN MARKET: RESEARCHSTATISTICS
FIGURE 25. GATIFLOXACIN MARKET: RESEARCHCONTACTS
FIGURE 26. GATIFLOXACIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GATIFLOXACIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GATIFLOXACIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY 200 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY 200 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GATIFLOXACIN MARKET SIZE, BY 400 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GATIFLOXACIN MARKET SIZE, BY 400 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GATIFLOXACIN MARKET SIZE, BY 0.3%, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GATIFLOXACIN MARKET SIZE, BY 0.3%, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GATIFLOXACIN MARKET SIZE, BY 200 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GATIFLOXACIN MARKET SIZE, BY 200 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GATIFLOXACIN MARKET SIZE, BY 400 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GATIFLOXACIN MARKET SIZE, BY 400 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GATIFLOXACIN MARKET SIZE, BY DERMAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GATIFLOXACIN MARKET SIZE, BY DERMAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GATIFLOXACIN MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GATIFLOXACIN MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GATIFLOXACIN MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GATIFLOXACIN MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GATIFLOXACIN MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GATIFLOXACIN MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GATIFLOXACIN MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GATIFLOXACIN MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GATIFLOXACIN MARKET SIZE, BY CHAIN RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GATIFLOXACIN MARKET SIZE, BY CHAIN RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDEPENDENT RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDEPENDENT RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 114. CANADA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 115. CANADA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 116. CANADA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 117. CANADA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 118. CANADA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 119. CANADA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. CANADA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. CANADA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. CANADA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. CANADA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. MEXICO GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. MEXICO GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. GERMANY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 226. GERMANY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 227. GERMANY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 228. GERMANY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 229. GERMANY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. GERMANY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. GERMANY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. GERMANY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. GERMANY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. FRANCE GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 244. FRANCE GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 245. FRANCE GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 246. FRANCE GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 247. FRANCE GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. FRANCE GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. FRANCE GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. FRANCE GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. FRANCE GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. FRANCE GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. ITALY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. ITALY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. ITALY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 278. ITALY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 279. ITALY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 280. ITALY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 281. ITALY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 282. ITALY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 283. ITALY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. ITALY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. ITALY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. ITALY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. ITALY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. ITALY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. SPAIN GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. SPAIN GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. SPAIN GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 296. SPAIN GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 297. SPAIN GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 298. SPAIN GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 299. SPAIN GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 301. SPAIN GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SPAIN GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SPAIN GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SPAIN GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SPAIN GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 308. SPAIN GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 309. SPAIN GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. SPAIN GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 348. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2024 (USD MILLION)
TABLE 352. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2025-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 354. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 356. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA GATIFLOXACIN MARKET SIZ

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Gatifloxacin market report include:
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Limited
  • Cipla Limited
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Torrent Pharmaceuticals Limited
  • Cadila Healthcare Limited
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 348.23 Million
Forecasted Market Value ( USD ) by 2030 $ 440.68 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gatifloxacin (CAS 112811-59-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Gatifloxacin (CAS 112811-59-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Balofloxacin Market by Indication (Respiratory Infections, Skin Infections, Urinary Tract Infections), Dosage Form (Eye Drops, Injectables, Oral Tablets), Distribution Channel, End User, Formulation Type, Patient Demographics - Global Forecast 2025-2030 - Product Image

Balofloxacin Market by Indication (Respiratory Infections, Skin Infections, Urinary Tract Infections), Dosage Form (Eye Drops, Injectables, Oral Tablets), Distribution Channel, End User, Formulation Type, Patient Demographics - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Aminoglycosides Market by Product Type (Amikacin, Gentamicin, Neomycin), Route Administration (Injectable, Oral, Topical), Application, Distribution Channel, Formulation - Global Forecast 2025-2030 - Product Image

Aminoglycosides Market by Product Type (Amikacin, Gentamicin, Neomycin), Route Administration (Injectable, Oral, Topical), Application, Distribution Channel, Formulation - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Image

Aminoglycosides Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Gatifloxacin Market

Gatifloxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to the class of drugs known as fluoroquinolones, which work by inhibiting the growth of bacteria. Gatifloxacin is used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections. It is also used to treat certain sexually transmitted diseases. Gatifloxacin is available in both oral and intravenous forms. Gatifloxacin is generally well tolerated, but it can cause side effects such as nausea, vomiting, diarrhea, and headache. It can also cause serious side effects such as tendon rupture, liver damage, and increased risk of tendinitis and tendon rupture. Gatifloxacin is available in generic form and is also sold under the brand names Tequin, Gatiflo, and Zagam. It is manufactured by several pharmaceutical companies, including GlaxoSmithKline, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.